T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.86B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.49B |
| 3 |
Broadcom
AVGO
|
+$1.29B |
| 4 |
Sempra
SRE
|
+$1.26B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$1.66B |
| 2 |
HCA Healthcare
HCA
|
+$1.02B |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$949M |
| 4 |
American Tower
AMT
|
+$931M |
| 5 |
FRC
First Republic Bank
FRC
|
+$890M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.29% |
| 2 | Technology | 17.01% |
| 3 | Financials | 16.32% |
| 4 | Consumer Discretionary | 14.01% |
| 5 | Industrials | 10.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
UGI
UGI
$7.6B
| $4.05M | ﹤0.01% |
86,187
+14,833
| +21% | +$709K |
|
1452
Chemours
CC
$2.37B
| $3.99M | ﹤0.01% |
79,777
-3,030
| -4% | -$159K |
|
1453
Owens Corning
OC
$12.2B
| $3.99M | ﹤0.01% |
43,370
-3,491
| -7% | -$294K |
|
1454
Enpro
NPO
$7.23B
| $3.96M | ﹤0.01% |
42,369
-10
| -0% | -$847 |
|
|
QVCGA
1455
DELISTED
QVC Group Inc Series A
QVCGA
| $3.82M | ﹤0.01% |
3,225
+44
| +1% | +$51K |
|
|
ACOR
1456
DELISTED
Acorda Therapeutics
ACOR
| $3.81M | ﹤0.01% |
1,481
-313
| -17% | -$890K |
|
1457
Petrobras Class A
PBR.A
$104B
| $3.75M | ﹤0.01% |
381,000
-258,000
| -40% | -$2.54M |
|
1458
Cedar Fair
FUN
$1.69B
| $3.7M | ﹤0.01% |
56,897
-1,000
| -2% | -$65.5K |
|
|
SCPH
1459
DELISTED
scPharmaceuticals
SCPH
| $3.68M | ﹤0.01% |
+304,709
| New | +$4.3M |
|
1460
ICICI Bank
IBN
$106B
| $3.68M | ﹤0.01% |
378,169
-138,181
| -27% | -$1.27M |
|
1461
Oshkosh
OSK
$9.49B
| $3.67M | ﹤0.01% |
40,345
-1,377
| -3% | -$121K |
|
1462
Twilio
TWLO
$36.2B
| $3.65M | ﹤0.01% |
154,864
-3,836,241
| -96% | -$108M |
|
1463
W.P. Carey
WPC
$16.4B
| $3.65M | ﹤0.01% |
54,024
+6,408
| +13% | +$438K |
|
|
SPR
1464
DELISTED
Spirit AeroSystems
SPR
| $3.59M | ﹤0.01% |
41,180
+1,049
| +3% | +$86.1K |
|
1465
Gaming and Leisure Properties
GLPI
$12.7B
| $3.54M | ﹤0.01% |
95,795
-2,500
| -3% | -$91K |
|
1466
Bloomin' Brands
BLMN
$902M
| $3.54M | ﹤0.01% |
165,981
-22,486
| -12% | -$431K |
|
1467
Ares Capital
ARCC
$14.4B
| $3.54M | ﹤0.01% |
225,000
| – | – |
|
1468
Thor Industries
THO
$4.11B
| $3.51M | ﹤0.01% |
23,298
+987
| +4% | +$137K |
|
1469
Cytokinetics
CYTK
$10.1B
| $3.48M | ﹤0.01% |
427,148
+1,890
| +0.4% | +$21.5K |
|
|
DLPH
1470
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
| $3.47M | ﹤0.01% |
+66,128
| New | +$3.44M |
|
1471
News Corp Class B
NWS
$17.9B
| $3.44M | ﹤0.01% |
206,920
-2,400
| -1% | -$36.6K |
|
1472
Tennant Co
TNC
$1.18B
| $3.42M | ﹤0.01% |
47,070
+20
| +0% | +$1.33K |
|
|
MRNS
1473
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $3.4M | ﹤0.01% |
+104,075
| New | +$2.8M |
|
|
NAUH
1474
DELISTED
National American University Holdings, Inc.
NAUH
| $3.38M | ﹤0.01% |
2,414,703
-41,800
| -2% | -$62.8K |
|
1475
Toronto Dominion Bank
TD
$204B
| $3.37M | ﹤0.01% |
57,287
-104
| -0.2% | -$5.94K |
|
Similar funds
T. Rowe Price Associates's Q4 2017 Portfolio in Review
As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Technology and Financials.
- T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
- T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
- T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
- T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
- T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
- T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.
Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.